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AbsTrACT
Objectives We investigate the independent and 
interacting long-term associations of occupational 
physical activity (OPa) and sport physical activity (spPa) 
with the incidence of coronary heart disease (chD) and 
cardiovascular diseases (cVD; chD plus ischaemic stroke) 
in north italian male workers.
Methods 3574 employed men aged 25–64 years, free 
of cVD at baseline, recruited in three population-based 
and one factory-based cohorts, were included in the 
analysis. the Baecke Questionnaire was used to assess 
OPa and spPa in ’minutes per week’ of moderate or 
vigorous Pa. We estimated the associations between 
different domains of Pa and the endpoints, adjusting for 
major cVD risk factors, using cox models.
results During a median follow-up of 14 years, 135 
and 174 first chD and cVD events, fatal and non-fatal, 
occurred. compared with the intermediate OPa tertile, 
the hrs for chD among low and high OPa workers were 
1.66 (95% ci 1.06 to 2.59) and 1.18 (0.72 to 1.94), 
respectively (P value=0.07). Decreasing trends in chD 
and cVD rates across increasing levels of spPa were also 
found, with an hr for cVD of 0.68 (0.46 to 0.98) for 
intermediate/recommended spPa compared with poor 
spPa. We also found a statistically significant spPa-OPa 
interaction, and the protective effect of spPa was only 
found among sedentary workers, for both endpoints. 
conversely, high OPa workers with intermediate/
recommended spPa levels had increased chD and cVD 
rates compared with the poor spPa category.
Conclusions Our results provide further evidence 
on the health paradox of OPa, with higher cVD rates 
among workers with intense Pa at work. Moreover, 
the protective effect on cVDs of spPa is prominent in 
sedentary workers, but it attenuates and even reverses in 
moderate and strenuous OPa workers.
InTrOduCTIOn
The 2015 Global Burden of Disease Study estimated 
that 15.2 million people died worldwide from coro-
nary heart disease (CHD) and stroke.1 In Europe 
alone, CHD accounts for 1.8 million deaths annu-
ally.2 Physical activity (PA) is known as an important 
modifiable protective factor for the development of 
CHD and as such it has been included as an inte-
gral component of more updated cardiovascular 
prevention guidelines.3 4 Since 2010, the Amer-
ican Heart Association (AHA) recommends adults 
to perform at least 150 min per week of moder-
ate-intensity activity or at least 75 min per week of 
vigorous-intensity activity, or at least 150 min per 
week of moderate and vigorous-intensity activi-
ties combined. These recommendations were inte-
grated into the WHO global recommendations on 
PA,5 and allow classifying adults into three classes: 
poor, including those who practice none PA; inter-
mediate, including those who practice PA without 
reaching the recommended minutes per week; 
and ideal, including those who practice PA for the 
recommended minutes per week.6 
While most studies consistently indicated 
that high levels of leisure time physical activity 
(LTPA) decrease the risk of cardiovascular disease 
(CVD),7–22 the relationship between occupational 
PA (OPA) and CVD has shown contradictory results. 
A few studies have reported both intermediate and 
high levels of OPA as protective factors for CHD 
and stroke9 15 16 or intermediate levels of OPA only 
as a protective factor for CVD mortality and inci-
dence.11 13 Conversely, other studies indicated that 
moderate and high levels of OPA increased the 
risk of major cardiovascular events.14 17 21 Finally, 
other studies did not find any association.12 19 Some 
studies have also estimated the interplay between 
LTPA and OPA on the CVD risk15 17 19–22 without 
univocal results, in particular concerning the effect 
of SpPA within groups exposed to intense OPA.
The aim of this study is to investigate the indepen-
dent and interacting associations between OPA and 
SpPA categories, the latter based on AHA recom-
mendations, and the incidence of coronary events 
in North Italian working men, over a follow-up of a 
median of 14 years.
MATerIAl And MeThOds
study samples
This study is a pooled analysis of three popu-
lation-based (the Multinational Monitoring of 
Trends and Determinants in Cardiovascular 
Disease (MONICA)—Brianza surveys II and III 
and the Pressioni Arteriose Monitorate e Loro 
Associazioni (PAMELA)—Study) and one facto-
ry-based (the Study of Employed in the Munic-
ipality of Milan (SEMM)—study) prospective 
cohorts of men aged 25 to 64 years, working as 
salaried employees (executive, white and blue-
collar workers).23 24 No written informed consent 
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signed by participants was required at time of recruitment. 
The study cohorts summed up to 3995 men who were free 
of CVD and currently employed at baseline. Women were not 
included in these analyses due to the low number of events 
during follow-up: 37 and 27 first coronary and ischaemic 
stroke events, respectively. A total of 421 men (10.5%) were 
excluded from the analysis due to missing information on 
CVD risk factors (n=175) or on PA (n=246). The final sample 
size consisted of 3574 male workers.
baseline risk factors assessment and follow-up procedures
Information on adopted procedures to measure CVD 
risk factors at baseline and to detect endpoints has been 
published23–25; we summarise here major methodological 
aspects. The MONICA, PAMELA and SEMM baseline risk 
factors assessments were carried out by a unique team between 
1989 and 1996. The overall participation rate was not <65%, 
with small variations among the four cohorts. Cardiovascular 
risk factors were collected adhering to the standardised proce-
dures and quality standards of the WHO-MONICA Project 
(http://www. thl. fi/ publications/ monica/ manual/ index. htm). 
In the PAMELA and in the SEMM studies, risk factors were 
measured based on MONICA-like procedures (see online 
supplementary material).
PA was measured using the Baecke Questionnaire,26 a known 
reliable and valid tool,27 to assess habitual PA. The question-
naire consists of 16 items from which an OPA score (eight 
items) and an SpPA index (four items) were derived. The OPA 
items investigated participant’s main occupation; his/her self-
rating of the work’s vigour as compared with workers of the 
same age; the frequency of sitting, standing, walking, lifting 
and sweating at work; and the frequency of fatigue after work. 
The OPA score was categorised in tertiles, with cut-offs at 2.5 
and 3.125 points (on a scale ranging from 1 to 5). Based on 
the method suggested by  Atherosclerosis Risk in Communities 
(ARIC) investigators,10 SpPA items were converted in ‘minutes 
per week’ of moderate or vigorous PA based on metabolic equiv-
alent of task,28 over the number of months annually performing 
the activities. The ‘minutes per week’ variable was then cate-
gorised into SpPA categories, according to AHA CVD health 
guidelines6: poor SpPA (0 min/week of activity); intermediate 
SpPA (1–149 min/week moderate or 1–74 min/week vigorous or 
1–149 min/week moderate plus vigorous activity); and recom-
mended SpPA (≥150 min/week moderate or ≥75 min/week 
vigorous or ≥150 moderate plus vigorous activity).
The same follow-up procedures were adopted for all cohorts, 
and people were followed until the end of 2008. The study 
endpoints were (1) a first acute coronary event as myocardial 
Table 1 Baseline demographic characteristics and CVD risk factors according to occupational PA categories
Occupational PA
P valuelow (n=1343) Intermediate (n=1227) high (n=1104)
Age, years (SD) 42.8 (9.1) 39.9 (8.9) 39.6 (9.2) <0.0001
Cohort type, %
  Population-based 42.1 33.0 43.0 <0.0001
  Factory-based 57.9 67.0 57.0
Occupational class, %
  Executives 20.7 8.3 5.6 <0.0001
  Non-manual and manual workers 79.3 91.7 94.4
Educational class*, %
  Low 22.5 35.8 55.8 <0.0001
  Intermediate 32.2 36.1 27.7
  High 45.4 28.1 16.5
Body mass index, kg/m2 26.2 26.4 26.5 0.13
Total cholesterol, mg/dL 217.3 217.0 214.4 0.15
HDL cholesterol, mg/dL 48.2 49.7 49.7 0.004
Total cholesterol/HDL cholesterol 4.80 4.66 4.60 0.001
Systolic BP, mm Hg 145.4 145.1 144.5 0.56
Diastolic BP, mm Hg 99.1 99.0 97.8 0.14
Antihypertensive treatment, % 6.3 5.0 5.2 0.32
Hypertension†, % 63.5 63.5 62.5 0.90
Current smoking, % 34.5 40.1 41.4 0.001
Diabetes, % 2.82 1.31 2.93 0.03
Alcohol intake*, %
  None 36.8 34.3 32.7 0.003
  Moderate (<50 gr/die) 56.9 58.6 57.4
  High (>50 gr/die) 6.3 7.1 9.9
Sport PA* , %
  Poor 64.0 69.1 77.7 <0.0001
  Intermediate 21.7 18.4 13.4
  Recommended 14.3 12.5 8.9
Men aged 25–64 years, free of CVD and current employed at baseline (n=3574). Age-adjusted mean (prevalence) at the age of 45 years, from linear (logistic) regression models.
*Prevalence estimated from a generalised logits model.
†Systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg or under antihypertensive treatment.
BP, blood pressure; CVD, cardiovascular disease; HDL, high-density lipoprotein; PA, physical activity. 
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infarction, acute coronary syndrome or coronary revascular-
isation whichever occurred first; and (2) a first major cardio-
vascular event, including in addition a first ischaemic stroke or 
carotid endarterectomy. Loss-to-follow-up rate was <4%, with 
no differences across study cohorts.
statistical analysis
We estimated the age-adjusted mean (prevalence) of major CVD 
risk factors by OPA and SpPA categories from linear (logistic) 
regression models, and tested differences among groups using 
the Wald χ2 test. A generalised logits model was used when-
ever the CVD risk factor had more than two levels. To esti-
mate the association of OPA and SpPA categories with the 
incidence of cardiovascular events, we used Cox proportional 
hazards models, including both SpPA and OPA indexes and 
(1) age, cohort type (population vs factory-based), educational 
level (low, intermediate and high); and (2) age, cohort type, 
educational level, total and high-density lipoprotein (HDL) 
cholesterol, systolic blood pressure, current smoking, diabetes, 
alcohol intake and body mass index (BMI). Since the association 
between SpPA categories and CVD risk was linear in the ARIC 
study10 as well as in our preliminary analysis on event rates, we 
tested for statistical trend by additionally running each model 
with SpPA treated as a continuous variable. To investigate the 
effect of the length of follow-up time on CVD risk, we plotted 
Kaplan-Meier survival curves across OPA and SpPA catego-
ries. Finally, we explored the protective role of SpPA among 
workers engaged in different levels of OPA by adding relevant 
SpPA-OPA interaction terms in age and CVD risk factor-ad-
justed Cox regression models, and formally testing the pres-
ence of additive interaction on the log(HR) scale with a Wald 
χ2 test. The analyses were performed using the Statistical Anal-
ysis System (V.9.4 release; SAS Institute, Cary, North Carolina, 
USA), while figures were drawn using R (V.3.1.3, 2015, The R 
Foundation for Statistical Computing, Wien, Austria).
resulTs
Among the included 3574 men, in a median follow-up time of 
14 years (IQR 12.9–15.9 years) 135 first fatal and non-fatal 
CHD events, and 174 CVD events, occurred. Age-adjusted 
demographic characteristics and CVD risk factor levels at base-
line for OPA and SpPA categories are shown in tables 1 and 2, 
respectively. Workers in high OPA were younger, less educated, 
with higher prevalence of current smokers and more than 50 gr 
per day alcohol consumers. People in the recommended SpPA 
category showed a better CVD risk factor profile, with lower 
mean levels of total cholesterol and BMI, higher median levels 
of HDL cholesterol and less current smokers.
Table 2 Baseline demographic characteristics and CVD risk factors according to sport PA categories
sport PA
P valuePoor (n=2231) Intermediate (n=737) recommended (n=606)
Age, years (SD) 42.8 (9.0) 38.7 (8.7) 36.8 (8.2) <0.0001
Cohort type, %
  Population-based 41.3 40.7 31.7 <0.0001
  Factory-based 58.7 59.3 68.3
Occupational class, %
  Executives 11.4 16.0 10.1 <0.01
  Non-manual and manual workers 88.6 84.0 89.9
Educational class*, %
  Low 40.1 26.3 29.8 <0.0001
  Intermediate 31.1 32.2 36.6
  High 28.7 41.5 33.6
Body mass index, kg/m2 26.5 26.0 26.1 <0.01
Total cholesterol, mg/dL 217.1 217.8 210.9 <0.01
HDL cholesterol, mg/dL 48.5 50.0 51.0 <0.0001
Total cholesterol/HDL cholesterol 4.77 4.64 4.42 <0.0001
Systolic BP, mm Hg 144.8 144.9 146.3 0.27
Diastolic BP, mm Hg 98.4 98.8 99.9 0.15
Antihypertensive treatment, % 6.0 4.2 5.3 0.23
Hypertension†, % 62.9 62.5 65.2 0.65
Current smoking, % 43.2 32.8 27.3 <0.0001
Diabetes, % 2.54 1.94 2.32 0.71
Alcohol intake*, %
  None 34.4 35.4 36.5 0.15
  Moderate (<50 gr/die) 57.4 57.9 58.2
  High (>50 gr/die) 8.3 6.7 5.3
Occupational PA*, %
  Low 37.6 48.4 47.1 <0.0001
  Intermediate 30.0 30.5 31.3
  High 32.4 21.1 21.7
Men aged 25–64 years, free of CVD and current employed at baseline (n=3574). Age-adjusted mean (prevalence) at the age of 45 years, from linear (logistic) models. 
*Prevalence estimated from a generalised logits model.
†Systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg or under anti-hypertensive treatment.
BP, blood pressure; CVD, cardiovascular disease; HDL, high-density lipoprotein; PA, physical activity. 
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The age, cohort and education-adjusted HRs and 95% CIs for 
the incidence of major CHD and CVD events across OPA and 
SpPA categories are shown in table 3. As these rates and HRs 
are mutually adjusted for the other type of PA, their estimates 
of the associations between two exposures (OPA and SpPA) 
with the endpoints are reciprocally independent. Keeping the 
intermediate OPA as the reference category, low OPA showed 
a significant higher age and educational class-adjusted CHD 
risk with HRs of 1.66 (95% CI 1.06 to 2.59) and high OPA an 
increased risk of 1.18 (0.72 to 1.94), but not reaching statistical 
significance. These results were not substantially modified when 
adjusting for other CHD risk factors, and were confirmed, with 
minor attenuations of HRs, for CVD as the endpoint.
Progressively decreased CHD risks were detected in the inter-
mediate and the recommended SpPA categories, in comparison 
to the poor SpPA category (χ2 test for trend borderline statically 
significant at 0.08), with an overall reduction of 28% in CHD 
risk when considering the two categories combined. Here, the 
adjustments for other CVD risk factors reduced the associations, 
as most of them can be considered as direct or indirect media-
tors. The results were consistent for the CVD endpoint, with the 
notable observation that the reduced risk across SpPA categories 
turned statistically significant (χ2 test for trend, P=0.04) and the 
HR when considering the two intermediate and recommended 
categories combined was 0.68 (0.46 to 0.98).
The Kaplan-Meyer survival curves show that the reduced 
CHD (figure 1A) and CVD (figure 1B) risks of intermediate and 
recommended SpPA in comparison to the poor SpPA category 
started from the very beginning of the follow-up period, and 
increased progressively. Similarly, the excessive risk of the low 
OPA category in comparison to the two other categories was also 
clearly detectable for both endpoints (figure 1C,D), but with the 
notable exception that the risks for poor OPA started to reveal 
later in the follow-up period (3–5 years after baseline). This 
latency time may explain some of the discrepancies of the results 
in the literature, when the follow-up time is short.
Table 4 reports the risk factor-adjusted HRs (with 95% CI) 
for SpPA in different OPA categories, and the formal test for 
SpPA-OPA interaction on CHD and CVD risks. The analyses 
were carried out combining the intermediate and recommend 
SpPA categories to be able to reach sufficient statistical power 
to test for statistical interaction. In low OPA workers, charac-
terised mainly by sedentary work activities, prominent protec-
tive effects of recommended or intermediate SpPA were seen, 
with consistent reduced HRs of 0.45 (95% CI 0.24 to 0.87) and 
0.45 (95% CI 0.25 to 0.82) for CHD and CVD, respectively, 
for the two active SpPA categories combined. These decreased 
HRs for higher levels of SpPA disappeared in the intermediate 
OPA category, and even reversed in the high OPA categories with 
values of 1.84 (0.88 to 3.87) for CHD and 1.66 (0.87 to 3.14) 
for CVD. The heterogeneity tests and the interaction tests were 
statically significant at an α level of 0.05, for both endpoints. 
The detrimental effect of SpPA among high OPA workers was 
even more pronounced when recommended SpPA levels were 
met (online supplementary table S1) and when taking into 
account commuting PA (walking or cycling to work for more 
than 30 min/day; online supplementary table S2).
dIsCussIOn
We found long-lasting (over a median 14 years of follow-up) and 
prominent protective effects of performing SpPA on CHD and 
Table 3 Age and multiple risk factor-adjusted HRs (with 95% CIs) for the incidence of CHD and CVD events across OPA and SpPA categories
n ev. no rate Model 1 Model 2 Model 1 Model 2
CHD events (n=135)
  OPA
   Low 1343 69 3.20 1.66 (1.06 to 2.59) 1.61 (1.02 to 2.52)
   Intermediate 1127 29 2.07 REF REF
   High 1104 37 2.61 1.18 (0.72 to 1.94) 1.26 (0.76 to 2.08)
   P value* 0.07 0.11
  SpPA
   Poor 2231 105 2.97 REF REF REF REF
   Intermediate 737 20 2.46 0.81 (0.50 to 1.32) 0.87 (0.53 to 1.42)
0.72 (0.47 to 1.09) 0.83 (0.54 to 1.27)   Recommended 606 10 1.78 0.58 (0.30 to 1.12) 0.76 (0.39 to 1.48)
   P value† 0.08 0.36 0.12 0.39
CVD events (n=174)
  OPA
   Low 1343 82 3.74 1.54 (1.04 to 2.29) 1.50 (1.01 to 2.23)
   Intermediate 1127 39 2.77 REF REF
   High 1104 53 3.77 1.18 (0.77 to 1.79) 1.20 (0.78 to 1.84)
   P value* 0.13 0.12
  SpPA
   Poor 2231 139 3.95 REF REF REF REF
   Intermediate 737 23 2.94 0.76 (0.49 to 1.20) 0.81 (0.51 to 1.27)
0.68 (0.46 to 0.98) 0.77 (0.53 to 1.14)   Recommended 606 12 2.24 0.58 (0.32 to 1.05) 0.72 (0.39 to 1.32)
   P value† 0.04 0.19 0.04 0.19
Men aged 25-64 years, free of CVD and currently employed at baseline (n=3574). Rates (x1000 person-years) are age-adjusted and estimated at the sample mean age.
Model 1: age, cohort, educational level, OPA and SpPA.
Model 2: model 1 plus body mass index, total cholesterol, HDL cholesterol, systolic BP, current smoking, diabetes and alcohol intake.
*Wald heterogeneity χ2 test (2 df).
†Wald trend χ2 test (1 df).
CHD, coronary heart disease; CVD, cardiovascular disease; HDL, high- density lipoprotein; OPA, occupational physical activity; SpPA, sport physical activity . 
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CVD risks in adult North Italian working men. These reduc-
tions, when intermediate and recommended levels of sport PA 
were combined, mounted to 28% for CHD and 32% for CVD, 
the latter being statistically significant. Similar results in men were 
reported by most of the previous primary and secondary studies 
for LTPA.10 14 17 18 21 22 For women, the results are less consistent, 
with a reduced CHD risk in a Finnish study,15 and with mostly null 
effects reported by another study.18 Furthermore, the protective 
effects in our study were only partially reduced when adjusting for 
behavioural and metabolic risk factors. In our data, lower prev-
alence of BMI and current cigarette smokers and means of total 
cholesterol with higher HDL cholesterol levels were found among 
those performing recommended levels of SpPA, indicating poten-
tial mediation effects of these factors. Other studies adjusted for 
different sets of demographic characteristics and CVD risk factors,14 
and this might explain in part the heterogeneity of their results.
Figure 1 Kaplan-Meyer survival curves for SpPA (top) and OPA (bottom) categories, for CHD (left side) and CVD (right side) endpoints. CHD, 
coronary heart disease; CVD, cardiovascular disease; OPA, occupational physical activity; SpPA, sport physical activity. 
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We focused on three categories of SpPA, based on AHA 
recommended levels,3 4 which can be derived from the Baecke 
Questionnaire, and are well characterised in terms of frequency, 
minutes per week and intensity. Most of other papers used LTPA, 
which includes a combination of sport and recreational (walking 
and bicycling during leisure time and for going to work) domains 
of PA.15 18 21 A few more recent studies better characterised PA 
in terms of frequency (times per week) and duration (minutes 
per session).17 22 The variety of LTPA definitions may explain 
in part the differences in estimating the size of the effects, as 
PA levels may have different meanings in different geographical, 
gender and age groups,10 and a non-quantitative scoring may not 
grasp such differences. The Baecke Questionnaire includes items 
exploring the recreational domain of LTPA. In our data, these 
items showed a poor internal correlation (Cronbach α coeffi-
cient <0.4), modest predictive ability (dissimilar single item–
endpoints associations) and reduced construct validity (only the 
item ‘During leisure time I walk’ loads the factor with an accept-
able coefficient of 0.72), indicating that walking was the single, 
main determinant of the LPTA score (data not shown). Due to 
this poor performance of these items, we excluded recreational 
LTPA from our analysis.
Our study found a statistically significant 66% increase in 
CHD incidence rates among workers with low levels of OPA, 
when compared with the intermediate OPA category and 
adjusting for SpPA as well as for other major CVD risk factors. 
We also estimated a 18% increase in both CHD and CVD risks 
among workers with higher levels of OPA, neither statistically 
significant. A recent meta-analysis12 reported similar results for 
the higher but not for the lower levels of OPA. The discrepan-
cies may be explained by the inclusion of different proportion 
of sedentary workers in the examined samples, as well as by the 
conjunct consideration of sport/LTPA (as discussed later in this 
paper). The higher CVD risk in sedentary people (mainly due 
to the work component) was also found in other studies.9 11 On 
the other hand, a Danish study21 did not find a higher risk in 
ischaemic heart disease mortality in sedentary work activities, 
but the different endpoint and the effect of Myocardial Infarc-
tion  (MI) survival should be acknowledged. A Swedish study19 
did not find an increase in risk of myocardial infarction in high 
OPA. Again, reasons for these discrepancies may be due to the 
different methods adopted for the assessment of OPA,10 14 and 
also to the differences in the length of follow-up, as can be seen 
in figure 1, where OPA differences in risk start to show up after 
3–5 years of follow-up.
In our study, the protective effect of AHA recommended 
and intermediate SpPA levels was strongly dependent of OPA 
level, with a prominent risk reduction among sedentary workers 
(55%), and an opposite relationship for workers with higher 
level of OPA increasing the risk up to 66% for CVD and 84% 
for CHD. These findings suggest that the strongest effect of 
SpPA can be detected among people involved in mainly seden-
tary jobs, in particular when recommended SpPA levels are met 
and when commuting PA is limited (online supplementary tables 
S1 and S2). Since these jobs mainly characterise white collars, 
the residual confounding of social class should be acknowledged, 
although we adjusted for the educational level. On the other 
hand, performing heavy physical working tasks and engaging in 
high levels of sport activities during leisure time may lead to 
premature exhaustion and fatigue, and generate an overloading 
of the cardiovascular system, which over years with insufficient 
recovery can lead to CVD.29 Our online supplementary mate-
rial findings on workers meeting recommended SpPA levels and 
with intense daily commuting PA strengthen our confidence to 
the main results, and provide further support to the overloading 
hypothesis. Moreover, this opposite effect of high SpPA among 
people with high levels of OPA may be a further explanation of 
the paradoxical adverse effect of OPA on CVD risk. In table 5, we 
report the effect of high versus low LTPA/SpPA in different OPA 
categories from published studies which addressed the interplay 
between OPA and LTPA/SpPA in working men. One study19 was 
not included as published results do not allow deriving compa-
rable calculations. A Belgian study,22 which adopted similar OPA 
assessment tools and endpoint (CHD incidence), did find the 
same results. Our study just extends these findings on a longer 
follow-up period. A Finnish15 and an Israeli17 study found a 
prominent protective effect of LTPA in low OPA categories only. 
Conversely, another Danish study, which used fatal ischaemic 
heart diseases only as the endpoint, found protective effects of 
LTPA over all OPA categories.21 Finally, Wang et al20 measured 
OPA adopting the relative aerobic strain or workload method, 
which takes into account both the absolute energy expenditure 
of the tasks and the workers’ individual aerobic capacity. In this 
study, the effect of LTPA was modest both in low and high OPA 
categories. Moreover, a recent report has shown that the benefi-
cial effect of LTPA increasing heart rate variability reduces when 
Table 4 Risk factor-adjusted HRs (with 95% CIs) for SpPA in different OPA categories, and test for SpPA-OPA interaction on the incidence of CHD 
and CVD events
OPA spPA n
Chd events (n=135) CVd events (n=174)
rate hr (95% CI) rate hr (95% CI)
Low Poor 799 4.09 REF 4.79 REF
Low Intermediate/recommended 544 1.56 0.45 (0.24 to 0.87) 1.86 0.45 (0.25 to 0.82)
Intermediate Poor 673 2.01 REF 2.98 REF
Intermediate Intermediate/recommended 454 2.29 1.20 (0.54 to 2.67) 2.41 0.93 (0.43 to 1.98)
High Poor 759 2.40 REF 3.57 REF
High Intermediate/recommended 345 3.56 1.84 (0.88 to 3.87) 4.98 1.66 (0.87 to 3.14)
Heterogeneity test P value* – – 0.02 – 0.01
Interaction test P value‡ ° – 0.02 – 0.01
Men aged 25–64 years, free of CVD and currently employed at baseline (n=3574). Rates (x1000 person-years) are age adjusted and estimated at the sample mean age.
Adjusted for age, cohort type (population-based vs factory-based), educational level, body mass index, total cholesterol, HDL cholesterol, systolic BP, current smoking, diabetes 
and alcohol intake.
*Waldχ 2 test (5 df).
†Waldχ 2 test for interaction (2 df).
BP, blood pressure; CHD, coronary  heart  disease; CVD, cardiovascular disease; HDL, high-density lipoprotein; OPA, occupational physical activity; SpPA, sport physical activity. 
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combined with higher OPA levels.30 Anyhow, more collaborative 
studies are needed to investigate the effects of LTPA/SpPA among 
workers with high OPA, adopting common and standardised 
methodologies.
Our study presents some limitations. First, PA was calculated 
using a self-administered questionnaire, once on the entire 
follow-up period. We can thus assume some bias due to misclas-
sifications of the exposures: in general, HRs of higher levels of 
both sport PA and OPA may be underestimated as people getting 
old moderate the former and are reallocated at work and reduce 
strenuous tasks. Although we adjusted for major risk factors, 
we do not have data on nutrition as a potential confounder. 
Another limitation is the focus on men only, as the low number 
of events among women determined very unstable effect esti-
mates, in particular for the OPA-SpPA interaction analyses. As 
mentioned, results in men and women can be heterogeneous 
because of both different levels of PA and different associations 
between PA domains and the CVD endpoint, so combining the 
two gender groups may be misleading and can produce confused 
findings. Finally, our data do not allow to further investigate the 
separate effects of walking and lifting at work on the CVD risk, 
as the large majority of high OPA workers (67%) reported both 
frequent walking and lifting.
In conclusion, our study conducted on North Italian male 
workers suggests a prominent protective effect of AHA recom-
mended and intermediate sport PA levels on CVDs among 
sedentary workers, and an opposite effect in people involved in 
physically demanding working tasks. The second finding partic-
ularly needs further investigations in other cohorts to assess 
consistency of the results. Due to the increasing number of 
sedentary workers in postindustrialised countries, interventions 
to promote SpPA in working populations could be an important 
factor to reduce the burden of CVDs. In addition, future CVD 
prevention guidelines4 should consider tailoring the recommen-
dations on the amount of PA during leisure time to the levels of 
PA at work.
Collaborators the cohorts collaborative study in northern italy (ccsni) research 
group: MOnica-Brianza cohorts: Pis: Professor Marco Mario Ferrario, Professor 
Key messages
What is already known on this subject?
While consistent evidence indicates that elevated and 
intermediate levels of leisure time physical activity decrease the 
risk of cardiovascular diseases (CVD), the relationship between 
occupational physical activity (OPA) levels and CVD has showed 
contrasting results.
What might this study add?
 ► Our study, conducted on North Italian male working cohorts, 
confirms the protective effect of both American Heart 
Association recommended and intermediate levels of sport 
activities, with a reduced CVD risk of 32%, as well as a 
paradoxical effect of higher CVD risks in low and high levels 
of OPA when compared with the intermediate level.
 ► The protective effect of recommended and intermediate 
sport physical activity (SpPA) levels strongly depends on OPA 
levels, with a prominent risk reduction among sedentary 
workers (55%), and an opposite relationship for workers with 
higher level of OPA increasing the risk up to 66% for CVD 
and 84% for coronary heart disease.
how might this impact on clinical practice?
The increasing number of sedentary workers in postindustrialised 
societies asks for specific interventions to promote SpPA even at 
the workplace. If our results were confirmed in larger studies, the 
CVD prevention recommendation of SpPA ought to consider the 
level of OPA.
Table 5 Age and multiple risk factor-adjusted HRs (with 95% CI) for incident CHD events on the effect of LTPA within occupational PA 
categories,published cohort studies, 2007–2016
First author, year Country endpoint
length of follow-
up (years)
Gender, 
age (years) 
no. of subjects, 
events
sport-lTPA 
levels
Occupational PA
low Intermediate high
Hu, 200715 Finland CHD, F+NF 18.9
Men,
25–64 22 877, 3073
Moderate to 
high vs low
0.77
(0.67 to 0.89)* NP 1.04*†
Women,
25–64 24 963, 1587
0.77
(0.66 to 0.91)* NP 0.79*†
Holtermann, 200921 Denmark IHD, F 30
Men,
40–59 4952, 591
Moderate to 
high vs low
0.70
(0.47 to 1.07)‡
0.75
(0.56 to 1.0)‡
0.65
(0.42 to 1.0)‡
Clays, 201322 Belgium CHD, F+NF 3.15
Men,
35–59 14 337, 87
Moderate to 
high vs low
0.52
(0.26 to 1.04)§ NP
2.3
(0.75 to 7.09)§
Harari, 201517 Israel CHD, F 22
Men,
20–70 4819, 170 Yes vs no 0.56†¶ NP 1.0† ¶
Wang, 201620 Finland AMI, F+NF 20
Men,
42–60 1891, 495 High vs low
0.95
(0.73 to 1.25)** NP
0.83
(0.57 to 1.21)**
Ferrario, present paper Italy
CHD, F+NF
14.2
Men,
25–64
3574, 135
Moderate to 
high vs low
0.45
(0.24 to 0.87)††§
1.20
(0.54 to 2.67)††
1.84
(0.88 to  3.87)††
CVD, F+NF 3574, 174
0.45
(0.25 to 0.82)††
0.93
(0.43 to 1.98)††
1.66
(0.87 to 3.14)††
*Adjusted for age, study year, education, alcohol, smoking, BMI, systolic BP, cholesterol and history of diabetes. HRs excluding PA due to commuting. 
†HRs computed from the reported values in the original tables. CIs are not estimable from the original tables.
‡Adjusted for age, BMI, systolic BP, diastolic BP, treatment of diabetes or hypertension, alcohol, smoking and occupational classes. 
§Adjusted for age, educational level, occupational class, job strain, BMI, smoking, alcohol, diabetes, systolic BP, total cholesterol and HDL cholesterol. 
¶Adjusted for age, socioeconomic status (number of people/room), educational status, father's country of origin, BMI, total cholesterol, HDL cholesterol, hypertension, diabetes, smoking, 
coffee consumption, alcohol, diet and  shift work. HRs for ‘low’ and ‘high’ OPA refer to the original ‘none-mild’ and ‘moderate-hard’ OPA categories (Table 3 of the reference). 
**Adjusted for age, education, participation in an unrelated clinical trial, smoking, alcohol, mental strain at work, social support at work and stress from work deadlines. 
††Adjusted for age, cohort, educational class, BMI, total cholesterol, HDL cholesterol, systolic BP, current smoking, diabetes and alcohol intake. 
AMI, acute myocardial infarction; BMI, body mass index; BP, blood pressure; CHD, coronary heart  disease; CVD, cardiovascular disease; F, Fatal; HDL, high-density lipoprotein; IHD, ischaemic 
heart disease; LTPA, leisure time physical activity; NF, non fatal; NP, data not present; PA, physical activity.
group.bmj.com on February 11, 2018 - Published by http://heart.bmj.com/Downloaded from 
8 Ferrario MM, et al. Heart 2018;0:1–8. doi:10.1136/heartjnl-2017-312594
Cardiac risk factors and prevention
giancarlo cesana; Baseline data collection: Professor r sega, Dr M t gussoni, Dr F 
Duzioni, sig l Bolognesi; Data quality assessment: Dr g Veronesi, Dr c Fornari, Dr 
l Bertù. PaMela study: Pi: Professor guido grassi. Professor r sega and Professor 
g Mancia (former Pis). Baseline data collection and follow-up activities: Professor 
r sega, Dr M Bombelli. Data quality assessment: Dr r Facchetti. seMM study: Pi: 
Professor Marco M Ferrario. Baseline data collection: Dr a Vivaldi. Data quality 
assessment: Dr g Veronesi, Dr c Fornari, Dr l Bertù. laboratory and biobanking: 
Professor P Brambilla, Dr s signorini. 
Contributors MMF originally conceived the research question. MMF, Mr and gV 
drafted the manuscript and MMF and gV prepared the revisions. MMF is the Pi of 
the seMM study. MMF and gc are co-Pis of the MOnica Brianza cohorts and gg is 
Pi for the PaMela study. gV was responsible for the statistical analyses. ah, Mc, ec, 
rB, gg and gc critically revised the text, with particular reference to the introduction 
and to the discussion sections.
Funding this work and the latest activities of the Brianza, PaMela and seMM 
cohorts have been funded by the health administration of the lombardia region 
(grants nos. 17155/2004 and 10800/2009). the follow-up was partially supported 
with grants from the italian Ministry of health (grant 2012/597) and it was carried 
out in collaboration with the Department for cardiovascular Dysmetabolic and 
ageing –associated Diseases of the istituto superiore di sanità in rome.
Competing interests none declared.
ethics approval the MOnica-Brianza and the PaMela studies were approved by 
the ethical committee of the University hospital of Monza (italy). the seMM study 
was approved by the ethical committee of the University hospital of Varese (italy). 
Provenance and peer review not commissioned; externally peer reviewed.
© article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. all rights reserved. no commercial use is permitted unless otherwise 
expressly granted.
reFerenCes
 1 gBD 2015 Mortality and causes of Death collaborators. global, regional, and 
national life expectancy, all-cause mortality, and cause-specific mortality for 249 
causes of death, 1980-2015: a systematic analysis for the global Burden of Disease 
study 2015. Lancet 2016;388:1459–544.
 2 townsend n, Wilson l, Bhatnagar P, et al. cardiovascular disease in europe: 
epidemiological update 2016. Eur Heart J 2016;37:3232–45.
 3 Us Department of health and human services. Physical activity guidelines for 
Americans. Washington, Dc: U.s. Department of health and human services, 2008.
 4 Piepoli MF, hoes aW, agewall s, et al. 2016 european guidelines on cardiovascular 
disease prevention in clinical practice: the sixth Joint task Force of the european 
society of cardiology and Other societies on cardiovascular Disease Prevention 
in clinical Practice (constituted by representatives of 10 societies and by invited 
experts)Developed with the special contribution of the european association for 
cardiovascular Prevention & rehabilitation (eacPr). Eur Heart J 2016;37:2315–81.
 5 World health Organization. Global recommendations on physical activity for health. 
geneva: World health Organization, 2010.
 6 lloyd-Jones DM, hong Y, labarthe D, et al. Defining and setting national goals 
for cardiovascular health promotion and disease reduction: the american heart 
association’s strategic impact goal through 2020 and beyond. Circulation 
2010;121:586–613.
 7 sofi F, capalbo a, cesari F, et al. Physical activity during leisure time and primary 
prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur 
J Cardiovasc Prev Rehabil 2008;15:247–57.
 8 nocon M, hiemann t, Müller-riemenschneider F, et al. association of physical activity 
with all-cause and cardiovascular mortality: a systematic review and meta-analysis. 
Eur J Cardiovasc Prev Rehabil 2008;15:239–46.
 9 Khaw Kt, Jakes r, Bingham s, et al. Work and leisure time physical activity assessed 
using a simple, pragmatic, validated questionnaire and incident cardiovascular 
disease and all-cause mortality in men and women: the european Prospective 
investigation into cancer in norfolk prospective population study. Int J Epidemiol 
2006;35:1034–43.
 10 Bell eJ, lutsey Pl, Windham Bg, et al. Physical activity and cardiovascular disease in 
african americans in aric. Med Sci Sports Exerc 2013;45:901–7.
 11 cheng X, li W, guo J, et al. Physical activity levels, sport activities, and risk of 
acute myocardial infarction: results of the interheart study in china. Angiology 
2014;65:113–21.
 12 li J, loerbroks a, angerer P. Physical activity and risk of cardiovascular disease: what 
does the new epidemiological evidence show? Curr Opin Cardiol 2013;28:575–83.
 13 autenrieth cs, Baumert J, Baumeister se, et al. association between domains of 
physical activity and all-cause, cardiovascular and cancer mortality. Eur J Epidemiol 
2011;26:91–9.
 14 li J, siegrist J. Physical activity and risk of cardiovascular disease--a meta-analysis of 
prospective cohort studies. Int J Environ Res Public Health 2012;9:391–407.
 15 hu g, Jousilahti P, Borodulin K, et al. Occupational, commuting and leisure-time 
physical activity in relation to coronary heart disease among middle-aged Finnish men 
and women. Atherosclerosis 2007;194:490–7.
 16 hu g, sarti c, Jousilahti P, et al. leisure time, occupational, and commuting physical 
activity and the risk of stroke. Stroke 2005;36:1994–9.
 17 harari g, green Ms, Zelber-sagi s. combined association of occupational and leisure-
time physical activity with all-cause and coronary heart disease mortality among a 
cohort of men followed-up for 22 years. Occup Environ Med 2015;72:617–24.
 18 hu gc, chien Kl, hsieh sF, et al. Occupational versus leisure-time physical activity in 
reducing cardiovascular risks and mortality among ethnic chinese adults in taiwan. 
Asia Pac J Public Health 2014;26:604–13.
 19 Johnsen aM, alfredsson l, Knutsson a, et al. association between occupational 
physical activity and myocardial infarction: a prospective cohort study. BMJ Open 
2016;6:e012692.
 20 Wang a, arah Oa, Kauhanen J, et al. effects of leisure-time and occupational 
physical activities on 20-year incidence of acute myocardial infarction: mediation and 
interaction. Scand J Work Environ Health 2016;42:423–34.
 21 holtermann a, Mortensen Os, Burr h, et al. the interplay between physical activity at 
work and during leisure time--risk of ischemic heart disease and all-cause mortality in 
middle-aged caucasian men. Scand J Work Environ Health 2009;35:466–74.
 22 clays e, De Bacquer D, Janssens h, et al. the association between leisure time physical 
activity and coronary heart disease among men with different physical work demands: 
a prospective cohort study. Eur J Epidemiol 2013;28:241–7.
 23 Ferrario M, sega r, cesana g. lessons from the MOnica study in northern italy.  
J Hypertens Suppl 1991;9:s7–s14.
 24 Ferrario MM, Veronesi g, chambless le, et al. the contribution of major risk factors 
and job strain to occupational class differences in coronary heart disease incidence: 
the MOnica Brianza and PaMela population-based cohorts. Occup Environ Med 
2011;68:717–22.
 25 Ferrario M, chiodini P, chambless le, et al. Prediction of coronary events in a low 
incidence population. assessing accuracy of the cUOre cohort study prediction 
equation. Int J Epidemiol 2005;34:413–21.
 26 Baecke Ja, Burema J, Frijters Je. a short questionnaire for the measurement of 
habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936–42.
 27 Jacobs Dr, ainsworth Be, hartman tJ, et al. a simultaneous evaluation of 10 
commonly used physical activity questionnaires. Med Sci Sports Exerc 1993;25:81–91.
 28 strath sJ, Kaminsky la, ainsworth Be, et al. guide to the assessment of physical 
activity: clinical and research applications: a scientific statement from the american 
heart association. Circulation 2013;128:2259–79.
 29 holtermann a, Krause n, van der Beek aJ, et al. the physical activity paradox: 
six reasons why occupational physical activity (OPa) does not confer the 
cardiovascular health benefits that leisure time physical activity does. Br J Sports 
Med 2017. doi: 10.1136/bjsports-2017-097965. epub ahead of print 10 aug 
2017.
 30 hallman DM, Birk Jørgensen M, holtermann a. On the health paradox of occupational 
and leisure-time physical activity using objective measurements: effects on autonomic 
imbalance. PLoS One 2017;12:e0177042.
group.bmj.com on February 11, 2018 - Published by http://heart.bmj.com/Downloaded from 
cardiovascular risk
occupational physical activity and 
Differing associations for sport versus
Grassi and Giancarlo Cesana
Holtermann, Els Clays, Rossana Borchini, Marco Cavicchiolo, Guido 
Marco Mario Ferrario, Mattia Roncaioli, Giovanni Veronesi, Andreas
 published online February 9, 2018Heart
 http://heart.bmj.com/content/early/2018/02/09/heartjnl-2017-312594
Updated information and services can be found at: 
These include:
References
 ef-list-1
http://heart.bmj.com/content/early/2018/02/09/heartjnl-2017-312594#r
This article cites 26 articles, 6 of which you can access for free at: 
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on February 11, 2018 - Published by http://heart.bmj.com/Downloaded from 
